JAG2 and rectal cancer: Furthermore, tRF/miR-1280 inhibits the 3' UTR of JAG2, reducing JAG2 biosynthesis to inhibit the Notch pathway and directly inhibit proliferation, migration and epithelial-mesenchymal transformation (EMT) of rectal cancer cells5, 49, 50.